In the absence of ligand, CXCR3 stabilizes active β-catenin, promoting leukemic proliferation, whereas CXCL10 engagement triggers β-catenin degradation and facilitates T-ALL cell migration. The gene discussed is CXCR3; the disease is acute lymphoblastic leukemia.